Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
The non-amyloid {beta} component (NAC) domain of alpha synuclein (Syn) drives Syn aggregation in Parkinson disease, yet as an intrinsically disordered segment it lacks a stable epitope for conventional ligand discovery. Using deep learning-based protein design, we generated compact single-chain binders that take advantage of the propensity of the NAC domain to adopt an extended {beta}-strand confo...
Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of real-world clinical data. Left unaddressed, these barriers prevent reliable disease modelling and hinder effective clinical evaluation. Conventional imputation strategies introduce systematic bias, distort inter-feature relationships, and yield overconf...
Background: Antimicrobial resistance poses a major threat to global public health. Large language models (LLMs) offer new possibilities for optimizing...
Emerging as a significant global health challenge, Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that causes memory loss and co...
Objectives: Explore the perspectives of primary caregivers towards pediatric tissue-based research participation. Design: Cross-sectional. Setting: Tw...
Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of rea...
Quantitative Structure-Activity Relationship ($\mathtt{QSAR}$) modeling is a foundational computational methodology in early-stage drug discovery, hea...
Parkinson disease (PD) progression is highly heterogeneous. Deeply phenotyped longitudinal research cohorts have enabled characterization of PD progre...
Background. Clostridioides difficile infection (CDI) imposes a burden that extends well beyond the gastrointestinal tract, yet existing outcome measur...
Background: Hypertension is a modifiable risk factor for dementia, yet the comparative effectiveness of angiotensin receptor blockers (ARBs) versus an...
Accurate and scalable assessment of quantitative neuroimaging biomarkers, such as white matter hyperintensities (WMH) and hippocampal (HIP) volumes, i...
Background: Lewy body diseases (LBD) collectively share alpha-synuclein Lewy pathology, yet present wide clinical heterogeneity, with overlapping moto...
Medical imaging pipelines routinely copy single-channel grayscale data into three identical RGB channels before classification, usually without justif...
In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits. Integrating these...
Human brain magnetic resonance imaging (MRI) revolutionized our ability to non-invasively probe individual differences in neuroanatomy. These anatomic...
Longitudinal dementia progression prediction is essential for clinical decision-making. However, models often degrade on external cohorts due to syste...
Cerebral microbleeds (CMBs) are MRI markers of small vessel disease and the microbleed component of amyloid related imaging abnormalities (ARIA-H), bu...
Alzheimers disease (AD) is a brain disorder that develops slowly and mainly affects memory, thinking, language, and daily activities. It is one of the...
INTRODUCTION: Accurate MRI-based identification of Alzheimer's disease (AD), mild cognitive impairment (MCI), and related dementias remains challengin...
Background: Polypharmacy is common in people living with dementia (PLwD) and associated with adverse outcomes. Although Structured Medication Reviews ...